BR112021016747A2 - Método para tratamento de um meloma múltiplo - Google Patents
Método para tratamento de um meloma múltiplo Download PDFInfo
- Publication number
- BR112021016747A2 BR112021016747A2 BR112021016747-1A BR112021016747A BR112021016747A2 BR 112021016747 A2 BR112021016747 A2 BR 112021016747A2 BR 112021016747 A BR112021016747 A BR 112021016747A BR 112021016747 A2 BR112021016747 A2 BR 112021016747A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- multiple myeloma
- subject
- pharmaceutical composition
- individual
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962812002P | 2019-02-28 | 2019-02-28 | |
| US62/812,002 | 2019-02-28 | ||
| PCT/US2020/019884 WO2020176610A1 (en) | 2019-02-28 | 2020-02-26 | Method for treating a multiple myeloma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112021016747A2 true BR112021016747A2 (pt) | 2021-10-19 |
Family
ID=72238680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112021016747-1A BR112021016747A2 (pt) | 2019-02-28 | 2020-02-26 | Método para tratamento de um meloma múltiplo |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220143016A1 (https=) |
| EP (1) | EP3931196A4 (https=) |
| JP (1) | JP2022521801A (https=) |
| CN (1) | CN113710670A (https=) |
| AU (1) | AU2020227748A1 (https=) |
| BR (1) | BR112021016747A2 (https=) |
| CA (1) | CA3131249A1 (https=) |
| EA (1) | EA202192117A1 (https=) |
| IL (1) | IL285800A (https=) |
| MX (1) | MX2021010398A (https=) |
| WO (1) | WO2020176610A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH593266A5 (https=) * | 1973-09-20 | 1977-11-30 | Delalande Sa | |
| EP1351691A4 (en) * | 2000-12-12 | 2005-06-22 | Cytovia Inc | SUBSTITUTED 2-ARYL-4-ARYLAMINOPYRIMIDINES AND ANALOGUES AS ACTIVATORS OF CASPASES AND APOPTOSIS INDUCERS, AND USE THEREOF |
| EP2624818B1 (en) * | 2010-10-05 | 2017-04-05 | Fresenius Kabi USA, LLC | Bortezomib formulations stabilised with boric acid |
| NZ746607A (en) * | 2012-11-21 | 2019-11-29 | Ptc Therapeutics Inc | Substituted reverse pyrimidine bmi-1 inhibitors |
| EA034866B1 (ru) * | 2013-08-30 | 2020-03-31 | ПиТиСи ТЕРАПЬЮТИКС, ИНК. | Замещенные пиримидиновые ингибиторы bmi-1 |
| EP3836932A2 (en) * | 2018-08-17 | 2021-06-23 | PTC Therapeutics, Inc. | Method for treating pancreatic cancer |
| US20220185795A1 (en) * | 2019-03-11 | 2022-06-16 | Ptc Therapeutics, Inc. | Compound form having enhanced bioavailability and formulations thereof |
-
2020
- 2020-02-26 WO PCT/US2020/019884 patent/WO2020176610A1/en not_active Ceased
- 2020-02-26 CN CN202080030185.4A patent/CN113710670A/zh active Pending
- 2020-02-26 BR BR112021016747-1A patent/BR112021016747A2/pt not_active Application Discontinuation
- 2020-02-26 MX MX2021010398A patent/MX2021010398A/es unknown
- 2020-02-26 US US17/433,106 patent/US20220143016A1/en not_active Abandoned
- 2020-02-26 AU AU2020227748A patent/AU2020227748A1/en not_active Abandoned
- 2020-02-26 EP EP20762789.4A patent/EP3931196A4/en active Pending
- 2020-02-26 JP JP2021550168A patent/JP2022521801A/ja active Pending
- 2020-02-26 EA EA202192117A patent/EA202192117A1/ru unknown
- 2020-02-26 CA CA3131249A patent/CA3131249A1/en active Pending
-
2021
- 2021-08-23 IL IL285800A patent/IL285800A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020227748A1 (en) | 2021-09-16 |
| CN113710670A (zh) | 2021-11-26 |
| WO2020176610A8 (en) | 2021-08-12 |
| IL285800A (en) | 2021-10-31 |
| EP3931196A4 (en) | 2022-12-14 |
| JP2022521801A (ja) | 2022-04-12 |
| CA3131249A1 (en) | 2020-09-03 |
| EA202192117A1 (ru) | 2021-11-23 |
| WO2020176610A1 (en) | 2020-09-03 |
| EP3931196A1 (en) | 2022-01-05 |
| MX2021010398A (es) | 2022-01-18 |
| US20220143016A1 (en) | 2022-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210353596A1 (en) | Combination treatment of cancer | |
| US11458126B2 (en) | DHODH inhibitor for use in treating hematologic cancers | |
| TWI688387B (zh) | 二氫槲皮素或其醫藥上可接受之鹽、或含有彼之組合物的醫藥用途 | |
| JP2025032069A (ja) | 膵臓癌を治療する方法 | |
| CN108472376A (zh) | 用于治疗癌症的合理组合疗法 | |
| BR112021016747A2 (pt) | Método para tratamento de um meloma múltiplo | |
| AU2020209767B2 (en) | Method for treating an acute myeloid leukemia | |
| RU2812782C2 (ru) | Способ лечения острого миелоидного лейкоза | |
| CN114096537B (zh) | 肉瘤治疗方法的有用组合 | |
| EA047152B1 (ru) | Способ лечения множественной миеломы | |
| EA046841B1 (ru) | Комбинации, пригодные в способе лечения саркомы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C07D 471/04 , C07D 403/04 , C07D 487/04 Ipc: C07D 471/04 (2006.01), C07D 403/04 (2006.01), C07D |
|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |